Literature DB >> 33489908

The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells.

David Bakhshinyan1, Neil Savage1, Sabra Khalid Salim1, Chitra Venugopal2, Sheila K Singh1,2.   

Abstract

During embryonic development, radial glial precursor cells give rise to neural lineages, and a small proportion persist in the adult mammalian brain to contribute to long-term neuroplasticity. Neural stem cells (NSCs) reside in two neurogenic niches of the adult brain, the hippocampus and the subventricular zone (SVZ). NSCs in the SVZ are endowed with the defining stem cell properties of self-renewal and multipotent differentiation, which are maintained by intrinsic cellular programs, and extrinsic cellular and niche-specific interactions. In glioblastoma, the most aggressive primary malignant brain cancer, a subpopulation of cells termed glioblastoma stem cells (GSCs) exhibit similar stem-like properties. While there is an extensive overlap between NSCs and GSCs in function, distinct genetic profiles, transcriptional programs, and external environmental cues influence their divergent behavior. This review highlights the similarities and differences between GSCs and SVZ NSCs in terms of their gene expression, regulatory molecular pathways, niche organization, metabolic programs, and current therapies designed to exploit these differences.
Copyright © 2021 Bakhshinyan, Savage, Salim, Venugopal and Singh.

Entities:  

Keywords:  glioblastoma stem cells; neural stem cells; neurogenic niche; tumor metabolism; tumor microenvironment

Year:  2021        PMID: 33489908      PMCID: PMC7820896          DOI: 10.3389/fonc.2020.603738

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  233 in total

Review 1.  Evolution of the Fgf and Fgfr gene families.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

Review 2.  Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later.

Authors:  Allison M Bond; Guo-Li Ming; Hongjun Song
Journal:  Cell Stem Cell       Date:  2015-10-01       Impact factor: 24.633

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.

Authors:  Takuichiro Hide; Tatsuya Takezaki; Yuka Nakatani; Hideo Nakamura; Jun-ichi Kuratsu; Toru Kondo
Journal:  Stem Cells       Date:  2011-04       Impact factor: 6.277

Review 5.  A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications.

Authors:  Xiaolin Fan; Yanzhen Xiong; Yuan Wang
Journal:  Front Med       Date:  2019-07-16       Impact factor: 4.592

6.  The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.

Authors:  Parvez Vora; Chitra Venugopal; Sabra Khalid Salim; Nazanin Tatari; David Bakhshinyan; Mohini Singh; Mathieu Seyfrid; Deepak Upreti; Stefan Rentas; Nicholas Wong; Rashida Williams; Maleeha Ahmad Qazi; Chirayu Chokshi; Avrilynn Ding; Minomi Subapanditha; Neil Savage; Sujeivan Mahendram; Emily Ford; Ashley Ann Adile; Dillon McKenna; Nicole McFarlane; Vince Huynh; Ryan Gavin Wylie; James Pan; Jonathan Bramson; Kristin Hope; Jason Moffat; Sheila Singh
Journal:  Cell Stem Cell       Date:  2020-05-27       Impact factor: 24.633

7.  Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.

Authors:  Yuki Hosokawa; Hisaaki Takahashi; Akihiro Inoue; Yuya Kawabe; Yu Funahashi; Kenji Kameda; Kana Sugimoto; Hajime Yano; Hironobu Harada; Shohei Kohno; Shiro Ohue; Takanori Ohnishi; Junya Tanaka
Journal:  Biochim Biophys Acta       Date:  2015-01-31

8.  Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

Authors:  Tadej Strojnik; Gro Vatne Røsland; Per Oystein Sakariassen; Rajko Kavalar; Tamara Lah
Journal:  Surg Neurol       Date:  2007-05-29

9.  Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma.

Authors:  Dongrui Wang; Renate Starr; Wen-Chung Chang; Brenda Aguilar; Darya Alizadeh; Sarah L Wright; Xin Yang; Alfonso Brito; Aniee Sarkissian; Julie R Ostberg; Li Li; Yanhong Shi; Margarita Gutova; Karen Aboody; Behnam Badie; Stephen J Forman; Michael E Barish; Christine E Brown
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.